THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Jorge Mendoza to Infliximab

Back to Details
This is a "connection" page, showing publications Jorge Mendoza has written about Infliximab.
Jorge Mendoza
Connection Strength
0.154
Infliximab
  1. Tuberculosis in Anti-Tumour Necrosis Factor-treated Inflammatory Bowel Disease Patients After the Implementation of Preventive Measures: Compliance With Recommendations and Safety of Retreatment. J Crohns Colitis. 2016 Oct; 10(10):1186-93.
    View in: PubMed
    Score: 0.127
  2. Role of TNFRSF1B polymorphisms in the response of Crohn's disease patients to infliximab. Hum Immunol. 2014 Jan; 75(1):71-5.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES